Log in

NASDAQ:HTWR - HeartWare International Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume528,597 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Heartware International, Inc is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:HTWR
CUSIP42236810
Phone+1-508-7390873

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive HTWR News and Ratings via Email

Sign-up to receive the latest news and ratings for HTWR and its competitors with MarketBeat's FREE daily newsletter.


HeartWare International (NASDAQ:HTWR) Frequently Asked Questions

What is HeartWare International's stock symbol?

HeartWare International trades on the NASDAQ under the ticker symbol "HTWR."

How were HeartWare International's earnings last quarter?

HeartWare International Inc (NASDAQ:HTWR) released its earnings results on Thursday, July, 28th. The medical instruments supplier reported ($0.43) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.82) by $0.39. The medical instruments supplier had revenue of $68.72 million for the quarter, compared to analyst estimates of $57.36 million. HeartWare International's quarterly revenue was down 6.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.47) earnings per share. View HeartWare International's Earnings History.

Has HeartWare International been receiving favorable news coverage?

News headlines about HTWR stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. HeartWare International earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for HeartWare International.

Who are some of HeartWare International's key competitors?

What other stocks do shareholders of HeartWare International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HeartWare International investors own include CHF Solutions (CHFS), Netflix (NFLX), Medivation (MDVN), Align Technology (ALGN), Anacor Pharmaceuticals (ANAC), Electronic Arts (EA), Express Scripts (esrx), Gilead Sciences (GILD), Lam Research (LRCX) and Micron Technology (MU).

What is HeartWare International's official website?

The official website for HeartWare International is http://www.heartware.com/.

How can I contact HeartWare International?

HeartWare International's mailing address is 500 Old Connecticut Path, FRAMINGHAM, MA 1701, United States. The medical instruments supplier can be reached via phone at +1-508-7390873.


MarketBeat Community Rating for HeartWare International (NASDAQ HTWR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  532 (Vote Outperform)
Underperform Votes:  415 (Vote Underperform)
Total Votes:  947
MarketBeat's community ratings are surveys of what our community members think about HeartWare International and other stocks. Vote "Outperform" if you believe HTWR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HTWR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Featured Article: Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel